Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chhinnavahni Kashaya Vati and Agnimantha Kwatha vs Metformin in Type 2 Diabetes
NCT05451147Phase 3Completed
- Sponsor
- Ayurvedic and Unani Tibbia College
- Start
- Sep 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of chhinnavahni kashaya vati and agnimantha kwatha in type 2 diabetes mellitus (T2DM), sponsored by Ayurvedic and Unani Tibbia College. Started Sep 2018; status: completed.
02
Drugs
chhinnavahni kashaya vatiagnimantha kwatha
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05451147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05451147.